Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SHUKRAPHAR.BOthis companyShukra Pharmaceuticals Limited	₹82.11	60.68×	14.9×	23.6×	40.04×	-87.5%	53.6%	44.6%	38.9%	24.6%	20.2%	-0.8%	0.02×	-0.12×	23.14×	3.6×	0.0%	3	—	2	C+
BALPHARMA.NSBal Pharma Limited	₹83.18	15.3×	1.17×	0.31×	7.34×	72.1%	24.4%	6.7%	2.0%	7.6%	8.2%	-4.2%	1.94×	4.5×	1.24×	1.05×	2.0%	2	—	2	C+
KOPRAN.NSKopran Limited	₹259.76	20.27×	0.98×	0.77×	10.71×	-111.9%	23.4%	8.9%	3.8%	4.9%	6.5%	-2.0%	0.29×	2.33×	5.77×	1.51×	2.8%	5	—	3	B-
KPL.BOKwality Pharmaceuticals Limited	₹3,856.75	20.13×	4.09×	2.69×	12.56×	-80.9%	33.9%	19.6%	13.4%	20.3%	15.8%	-2.9%	0.39×	1.1×	8.97×	1.8×	0.0%	4	—	2	C
LINCOLN.NSLincoln Pharmaceuticals Limited	₹520.85	12.87×	1.49×	1.69×	8.5×	161.8%	32.8%	12.4%	13.1%	11.6%	8.1%	7.2%	0.01×	-0.13×	82.12×	5.25×	0.3%	4	—	3	B+
REMUS.NSRemus Pharmaceuticals Ltd.	₹820.50	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Peer median	—	17.71×	1.33×	1.23×	9.6×	-4.4%	28.6%	10.6%	8.4%	9.6%	8.1%	-2.4%	0.34×	1.72×	7.37×	1.66×	1.2%	4	—	3	—